Bulgaria to spend over 12 mln euro on COVID-19 medication, vaccines

Bulgaria to spend over 12 mln euro on COVID-19 medication, vaccines

Bulgaria's government said it approved the allocation of a further 20. 4 million levs ($12.4 million/10. 4 million euro) from the health ministry budget to COVID-19 vaccines and medication.

About 6. 4 million levs of the total will go towards the EU's Emergency Support Instrument (ESI), which will ensure the country better access to coronavirus vaccines, the government said on Thursday.

The ESI is the financing arm of the Joint European Roadmap towards lifting coronavirus containment measures.  The instrument helps mitigate the immediate consequences of the pandemic and anticipate the needs related to the exit and recovery.

The government also gave the green light to the health ministry to spend 14 million levs to procure 17,280 flacons of remdesivir by the end of the year.

Remdesivir is manufactured by US-based company Gilead Sciences and sells under the Veklury brand name.  Clinical trials have shown that Remdesivir speeds up the recovery of patients with COVID-19.  Veklury was the first medicine approved by the European Commission for treatment of COVID-19.

Previous Next
Close
Test Caption
Test Description goes like this
Cookies Preferences
Choose Type of Cookies You Accept Using


These cookies are required for the website to run and cannot be switched off. Such cookie are only set in response to actions made by you such as language, currency, login session, privacy preferences. You can set your browser to block these cookies but our site may not work then.


These cookies allow us to measure visitors traffic and see traffic sources by collecting information in data sets. They also help us understand which products and actions are more popular than others.


These cookies are usually set by our marketing and advertising partners. They may be used by them to build a profile of your interest and later show you relevant ads. If you do not allow these cookies you will not experience targeted ads for your interests.